Last reviewed 2026-04-22 · How we verify

A. Paniculata and A. Chilensis

A herbal combination derived from Andrographis paniculata and Andrographis chilensis that modulates immune function and reduces inflammation through multiple phytochemical constituents.

A herbal combination derived from Andrographis paniculata and Andrographis chilensis that modulates immune function and reduces inflammation through multiple phytochemical constituents. Used for Immune support and inflammatory conditions (Phase 3 indication not publicly specified).

At a glance

Mechanism of action

Andrographis species contain andrographolide and related diterpene lactones that inhibit NF-κB signaling and pro-inflammatory cytokine production. The combination formulation is designed to enhance immunomodulatory and anti-inflammatory effects, potentially supporting immune response and reducing inflammatory markers in various disease states.

Approved indications

• Immune support and inflammatory conditions (Phase 3 indication not publicly specified)

Common side effects

• Gastrointestinal disturbance
• Allergic reactions

Key clinical trials

• To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• A. Paniculata and A. Chilensis CI brief — competitive landscape report
• A. Paniculata and A. Chilensis updates RSS · CI watch RSS
• Vedic Lifesciences Pvt. Ltd. portfolio CI